275 related articles for article (PubMed ID: 24048331)
1. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.
Liu R; Li X; Gao W; Zhou Y; Wey S; Mitra SK; Krasnoperov V; Dong D; Liu S; Li D; Zhu G; Louie S; Conti PS; Li Z; Lee AS; Gill PS
Clin Cancer Res; 2013 Dec; 19(24):6802-11. PubMed ID: 24048331
[TBL] [Abstract][Full Text] [Related]
2. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
[TBL] [Abstract][Full Text] [Related]
3. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
Wang H; Li D; Liu S; Liu R; Yuan H; Krasnoperov V; Shan H; Conti PS; Gill PS; Li Z
J Nucl Med; 2015 Jun; 56(6):908-13. PubMed ID: 25908833
[TBL] [Abstract][Full Text] [Related]
4. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.
Lin YG; Shen J; Yoo E; Liu R; Yen HY; Mehta A; Rajaei A; Yang W; Mhawech-Fauceglia P; DeMayo FJ; Lydon J; Gill P; Lee AS
Oncogene; 2015 Oct; 34(43):5418-26. PubMed ID: 25684138
[TBL] [Abstract][Full Text] [Related]
5. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.
de Ridder GG; Ray R; Pizzo SV
Melanoma Res; 2012 Jun; 22(3):225-35. PubMed ID: 22495669
[TBL] [Abstract][Full Text] [Related]
6. Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non-Small Cell Lung Cancer Cell Lines and Tumor Models.
Dadey DYA; Kapoor V; Hoye K; Khudanyan A; Collins A; Thotala D; Hallahan DE
Clin Cancer Res; 2017 May; 23(10):2556-2564. PubMed ID: 27815359
[No Abstract] [Full Text] [Related]
7. CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
Lin ML; Chen SS; Ng SH
Anticancer Res; 2015 Oct; 35(10):5359-68. PubMed ID: 26408697
[TBL] [Abstract][Full Text] [Related]
8. Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production.
Zhang Y; Tseng CC; Tsai YL; Fu X; Schiff R; Lee AS
PLoS One; 2013; 8(11):e80071. PubMed ID: 24244613
[TBL] [Abstract][Full Text] [Related]
9. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.
Wey S; Luo B; Tseng CC; Ni M; Zhou H; Fu Y; Bhojwani D; Carroll WL; Lee AS
Blood; 2012 Jan; 119(3):817-25. PubMed ID: 21937694
[TBL] [Abstract][Full Text] [Related]
10. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
11. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells.
Misra UK; Pizzo SV
Cancer Biol Ther; 2010 Jan; 9(2):142-52. PubMed ID: 20368692
[TBL] [Abstract][Full Text] [Related]
12. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
[TBL] [Abstract][Full Text] [Related]
13. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
14. Cell surface GRP78 facilitates hepatoma cells proliferation and migration by activating IGF-IR.
Yin Y; Chen C; Chen J; Zhan R; Zhang Q; Xu X; Li D; Li M
Cell Signal; 2017 Jul; 35():154-162. PubMed ID: 28389416
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
[TBL] [Abstract][Full Text] [Related]
16. GRP78 secreted by colon cancer cells facilitates cell proliferation via PI3K/Akt signaling.
Fu R; Yang P; Wu HL; Li ZW; Li ZY
Asian Pac J Cancer Prev; 2014; 15(17):7245-9. PubMed ID: 25227822
[TBL] [Abstract][Full Text] [Related]
17. Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake.
Shang Y; Mao Y; Batson J; Scales SJ; Phillips G; Lackner MR; Totpal K; Williams S; Yang J; Tang Z; Modrusan Z; Tan C; Liang WC; Tsai SP; Vanderbilt A; Kozuka K; Hoeflich K; Tien J; Ross S; Li C; Lee SH; Song A; Wu Y; Stephan JP; Ashkenazi A; Zha J
Mol Cancer Ther; 2008 Sep; 7(9):2599-608. PubMed ID: 18790743
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth.
Chandarlapaty S; Scaltriti M; Angelini P; Ye Q; Guzman M; Hudis CA; Norton L; Solit DB; Arribas J; Baselga J; Rosen N
Oncogene; 2010 Jan; 29(3):325-34. PubMed ID: 19855434
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
